A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study

Acceptance of healthcare-associated pneumonia (HCAP) as an entity and the associated risk of infection by potentially multidrug-resistant (MDR) organisms such as methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas and Acinetobacter have been debated. We therefore compared patients with H...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC infectious diseases 2013-11, Vol.13 (1), p.561-561, Article 561
Hauptverfasser:	Quartin, Andrew A, Scerpella, Ernesto G, Puttagunta, Sailaja, Kett, Daniel H
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - therapeutic use Acinetobacter Aged Aged, 80 and over Anti-Bacterial Agents - therapeutic use Bacteria - classification Bacteria - genetics Bacteria - isolation & purification Bacterial pneumonia Comorbidity Complications and side effects Cross infection Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Demographics Demography Drug dosages Drug resistance in microorganisms Ethics Female Geography Health aspects Health facilities Hospital patients Hospitalization Hospitals Humans Linezolid Male Microbiology Middle Aged Mortality Nosocomial infections Nursing homes Ostomy Oxazolidinones - therapeutic use Parenteral nutrition Pharmaceutical industry Pneumonia Pneumonia, Ventilator-Associated - drug therapy Pneumonia, Ventilator-Associated - epidemiology Pneumonia, Ventilator-Associated - microbiology Pseudomonas aeruginosa Retrospective Studies Review boards Risk Factors Staphylococcal infections Staphylococcus aureus Staphylococcus infections Studies Vancomycin - therapeutic use Ventilation Ventilators Wound healing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Acceptance of healthcare-associated pneumonia (HCAP) as an entity and the associated risk of infection by potentially multidrug-resistant (MDR) organisms such as methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas and Acinetobacter have been debated. We therefore compared patients with HCAP, hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) enrolled in a trial comparing linezolid with vancomycin for treatment of pneumonia. The analysis included all patients who received study drug. HCAP was defined as pneumonia occurring
ISSN:	1471-2334 1471-2334
DOI:	10.1186/1471-2334-13-561